Many physicians believe that the hyperventilation syndrome is invariably associated with anxiety or undiagnosed organic disease such as asthma and pulmonary embolus, or both. Twenty one patients referred by specialist physicians with unexplained somatic symptoms and unequivocal chronic hypocapnia (resting end tidal Pco2. < 4 kPa (30 mm Hg) on repeated occasions during prolonged measurement) were investigated. All but one complained of inability to take a satisfying breath. Standard lung function test results and chest radiographs were normal in all patients, but histamine challenge showed bronchial hyper-reactivity in two of 20 patients tested, and skin tests to common allergens were positive in three of 18. Ventilation-perfusion scanning was abnormal in a further three of 15 patients studied, with unmatched perfusion defects in two and isolated ventilation defects in one. None of the 21 had thyrotoxicosis, severe coronary heart disease, or other relevant cardiovascular abnormalities. Ten of the 21 patients were neurotic and suffered from chronic psychiatric disturbance characterised by anxiety, panic, and phobic symptoms. The remainder had no detectable psychiatric disorders but reported proportionately more somatic than anxiety symptoms.
Introduction
The hyperventilation syndrome remains largely unrecognised in clinical practice despite numerous reports since the original description in 1937.1 This may be due to a lack of widely accepted, unequivocal diagnostic criteria based on objective measurements. Apart from tetany, which is rare, symptoms and signs are diverse and non-specific, providing an unsatisfactory basis for diagnosis.2 Lum claimed that spot measurements of PAco., in the normal range can be consistent with the diagnosis,3 which suggests that hypocapnia may occur at other times. This assumption may not always be justified. Hyperventilation is a physiological term implying arterial hypocapnia and should be objectively documented before a diagnosis is made. Because of these uncertainties the hyperventilation syndrome has been diagnosed in patients with little in common, usually according to the bias of the doctor concerned.
Factors that initiate and sustain the hyperventilation syndrome are obscure. It has been said to represent a non-specific manifestation of anxiety4 or be synonymous with Da Costa's syndrome and other functional cardiovascular disorders.5 6 Academic Department of Psychological Medicine Correspondence to: Dr Christopher Bass. Lum suggested that it is a habit disorder with exaggerated thoracic breathing. 3 Organic diseases can cause hyperventilation and hypocapnia7 h but can also coexist with the hyperventilation syndrome. Many physicians believe that the hyperventilation syndrome is always secondary to undiagnosed organic diseases.9 Certainly, it should not be diagnosed until relevant organic disorders have been excluded. Asthma,i" pulmonary embolus," and parenchymal lung disorders are known causes of hyperventilation. They may not be obvious clinically or after standard investigations and may require specialised procedures for detection.
Anxious Ventilation-perfusion scans were abnormal in three patients. A 37 year old woman (case 1) with extreme hypocapnia and a history suggestive of recurrent bronchitis showed patchy ventilation defects unmatched by perfusion defects. Fibreoptic bronchoscopy showed intrabronchial pus growing Streptococcus pneumoniae and Haemophilus influenzae but no endobronchial abnormalities.
In a 69 year old man (case 8) with breathlessness and sighing that began when a pacemaker was inserted six months previously the scan showed perfusion defects suggestive of resolving pulmonary embolus. Despite normal results of lung function tests and chest radiography arterial Po2 was reduced at 8 7 kPa (65 mm Hg). Resting ventilation, increased at 14 5 1/min, was unaffected by raised inspired oxygen. These findings were unchanged after four months of anticoagulant treatment.
In a third patient (case 4) the scan showed a perfusion defect in the middle of the left lobe, but all other tests, including those of blood gases, yielded normal results apart from low Pco2.
Serum thyroxine concentrations were normal in all as were the results of gastrointestinal, cardiac, and neurological investigations.
PSYCHIATRIC ASSESSMENT
Ten patients had evidence of psychiatric illness and were designated psychiatric cases. Most had multiple somatic and psychic symptoms of anxiety, and nine reported panic, which occurred either spontaneously, in relation to circumscribed situations such as crowds, or in response to disagreeable symptoms such as palpitations. Seven had clinical phobic neuroses with limitation of activities. Another eight reported mild phobic symptoms but without avoidance behaviour. Thus all but six of the 21 patients reported phobic symptoms of some description.
Eleven patients were designated non-cases with composite scores of 12 or less in the clinical interview schedule. They had appreciably lower mean scores of neuroticism and a shorter history of symptoms than the cases (table III) .
Mean anxiety and depression scores on the Kellner scale were also considerably higher in the psychiatric cases. These findings, together with the difference in scores of neuroticism, validated the distinction between cases and non-cases. The ratio of somatic score to anxiety score, however, was greater for the non-cases (mean 1 30 (SE 0 12)) than the cases (mean 1 04 (0 05); p=009, MannWhitney U test), suggesting that the non-cases reported proportionately more somatic than anxiety symptoms.
There were inverse correlations between the lowest value for PAco, and overall score in the clinical interview schedule (r= -042; p < 005), overall Kellner score (r= -0 46; p < 0-05), and score of neuroticism (r= -0 23; NS).
Nine of the 10 psychiatric cases had a history of treatment for psychiatric disorders; most of them were neurotic with multiple somatic complaints and had made repeated visits to both hospital outpatient departments and emergency rooms. One neurotic patient (case 6) with a six year history of multiple somatic complaints attributed all her symptoms to food allergies. She ventilation was made. All of these patients could clearly date the onset of their complaints, and six reported mild phobic symptoms, which had not led to any recent limitation of activities. It was not ethically justifiable to undertake the more invasive or expensive clinical investigations in all subjects. Nevertheless, there were at least six patients (cases 3, 7, 11, 14, 17, and 20) in whom the most exhaustive investigations failed to show any conspicuous psychiatric or organic disturbance apart from profound hypocapnia and (in cases 7, 14, and 17) mild longstanding phobic traits. These patients were remarkable for their apparent normality.
We searched for a common unifying characteristic in these patients. The only clinical feature common to all but one was the complaint of "air hunger."
Discussion
The most important finding from this study is that some patients can have profound hypocapnia with no evidence of either organic or apparent psychiatric disorder. The cause of this hypocapnia is unknown. These patients could be classified as having the hyperventilation syndrome, but becauseof lack of consensus regarding cause, diagnosis, and classification we prefer the more descriptive term chronic hyperventilation of unknown cause.
The chronicity of hyperventilation in our patients has been characterised elsewhere', and was confirmed by repeated measurement of hypocapnia in the absence of acute episodes. Our sample was biased against patients with acute hyperventilation related to attacks of panic, but acute and chronic forms are not mutually exclusive. We used criteria for hypocapnia more stringent than those usually quoted but which reflect the current uncertainty about the normal range of PAco.,.
Our criteria for selection do not permit us to draw conclusions about the prevalence of organic disease in a community sample of patients with hyperventilation. In our group 19 (90 " O) showed normal bronchial reactions to histamine, and a further 12 out of 15 had normal ventilation and perfusion scans, suggesting that severe hyperventilation can occur in the absence of asthma, pulmonary embolus, and lung parenchymal disorder. We were unable to show that hyperventilation in the five patients with respiratory abnormalities was a consequence of their underlying lung disease, although hyperventilation has been documented in these disorders. I0 Nevertheless, we consider that no patient should be diagnosed as having the hyperventilation syndrome without prior investigation for evidence of asthma, pulmonary embolus, and intrinsic lung disease. Chest radiography and standard lung functoin tests can be normal in the presence of these disorders. expressed psychological distress through the presentation of physical complaints2'; the finding of proportionately more somatic symptoms in this group was in keeping with this suggestion. The detection of psychiatric abnormalities and traits of neuroticism in the remainder may not explain the pathogenesis of the hyperventilation syndrome in these subjects. Lum claimed that anxiety may be a consequence of disagreeable and undiagnosed physical symptoms rather than a primary disorder. 3 Like Garssen et al we found phobic symptoms in about two thirds of our patients. 13 It is not commonly recognised that patients with phobic neuroses and disorders of panic may suffer from chronic, unstable, hypocapnic breathing, which may lead to various alarming somatic complaints.2 One such phobic patient attributed all her symptoms to multiple food allergies despite evidence to the contrary. Patients attending food allergy clinics may have symptoms that are a consequence of chronic hyperventilation as Rix et a, showed. 28 Inverse correlations between PAco ., and scores of both neuroticism and psychiatric morbidity have been reported by others.12 29 Neurotic patients may be easily distressed by the symptoms of transient hypocapnia, which may then lead to increased arousal, further hyperventilation, and the establishment of a chronic disorder.3 31 Wrong attribution of these hypocapnic symptoms to serious organic diseases may be another factor responsible for maintaining high levels of arousal. But half our patients had scores of neuroticism in the normal range, suggesting that other mechanisms were involved. Further research is required to determine which biological and psychosocial factors predispose towards the development of this common and underdiagnosed disorder.
SHORT REPORTS Intranasal calcitonin and plasma calcium concentrations in normal subjects
Various substances are absorbed by the mucosa of the respiratory system, including vasopressin, leuteinising hormone releasing hormone, insulin, and glucagon.'-4 We have evaluated the absorption of another polypeptide hormone, calcitonin, through the nasal mucosas of normal subjects.
Subjects, methods, and results
We studied six healthy volunteers, all doctors or medical students aged 25-30, with no family history of endocrine or metabolic diseases. After an overnight fast and abstention from smoking they were studied in bed in the morning. Calcitonin was given intravenously or intranasally according to a randomised crossover design. Tests were performed twice in each patient with an interval of one week.
Human calcitonin (Cibacalcin; Ciba-Geigy) 500 ,ug was either administered intravenously or mixed with a surfactant, sodium glycocholate 15 mg, dissolved in 0 5 ml distilled water, and given as nose drops. Four subjects also received intranasally calcitonin 1000 ALg plus sodium glycocholate 15 mg on a separate occasion. The project was approved by this hospital's ethical committee.
The figure shows the times at which blood samples were taken for plasma calcitonin and ionised calcium assay. Calcitonin concentrations were determined by radioimmunoassay with reagents supplied by Sorin-Biomedica (Saluggia, Italy). In our experience, the main characteristics of this radioimmunoassay are: sensitivity 10 pg/ml; recovery of added doses 92%; and interassay and intra-assay coefficients of variation 8-5°h and 4 40', respectively.
The figure compares the effects of intravenously and intranasally administered calcitonin and of 500 and 1000 ,ug calcitonin administered intranasally on plasma concentrations of calcitonin and ionised calcium. Although plasma calcitonin concentrations were consistently higher after intravenous than after intranasal administration of the same dose, calcitonin 500 ug affected plasma calcium concentrations identically whether given intranasally or intravenously. Higher plasma calcitonin concentrations accompanied the higher dose of intranasal calcitonin, but the decrease in plasma calcium concentrations did not differ between the two doses.
Severity of side effects did not differ between either the two routes of administration or the two doses given intranasally. Five subjects experienced nausea and facial flush, one with vomiting.
Comment
Administration of peptidic hormones (insulin, calcitonin) is restricted to the parenteral route as proteolytic digestion prevents administration by mouth.5 This is a drawback to long term treatment with peptidic hormones and limits the compliance by patients, especially when a regimen of regular daily injections is required. We therefore studied the possible efficacy of intranasally administered calcitonin in normal subjects. To evaluate both the kinetics and the short term effects of calcitonin the hormone was administered intranasally and intravenously. A fixed dose of human calcitonin,
